EUVIMEDEUVIMED entdecken
KommentarOpen Access

The two faces of MyoD: repressor and activator of gene expression during myogenesis

Carmen Birchmeier

Genes & Development · 2025

DOI: 10.1101/gad.353232.125 ↗

Kurz gefasst

Kommentar in der Zeitschrift Genes & Development, 2025. Verfasst von Carmen Birchmeier. Beteiligte Einrichtung: Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft, 13125 Berlin, Germany; Neurowissenschaftliches Forschungzentrum, NeuroCure…. Hauptthemen laut MEDLINE: Gene Expression Regulation, Developmental, Muscle Development, MyoD Protein, Repressor Proteins. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MyoD is well known for its ability to reprogram a broad range of cell types into myogenic cells and for its pioneer function in activating the myogenic program during muscle development and regeneration. The basic helix–loop–helix (bHLH) protein achieves this by directly binding to E-boxes in DNA and recruiting proteins like histone acetyltransferases and the SWI/SNF chromatin remodeling complex. Interestingly, Nicoletti and colleagues (doi:10.1101/gad.352708.125) report in this issue of Genes & Development an unexpected finding; namely, that MyoD can also act as a repressor. This repressive activity is E-box-independent, meaning that MyoD can be indirectly recruited to distinct sites in chromatin. Transcription factor motifs enriched at these sites correspond to E2F, NF-Y, and Jun/Fos motifs. The genes that are repressed by this noncanonical MyoD function control nonmyogenic fates and participate in cell cycle regulation as well as proliferation. At such sites, MyoD binding is associated with chromatin compaction and repression of transcription.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene Expression Regulation, DevelopmentalMuscle DevelopmentMyoD ProteinRepressor ProteinsAnimalsHumansChromatin

Stichwörter der Autor:innen

MYODchromatingene expression

Substanzen

ChromatinMyoD ProteinMyoD1 myogenic differentiation proteinRepressor Proteins

Autor:innen und Institutionen

  • Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft, 13125 Berlin, Germany; Neurowissenschaftliches Forschungzentrum, NeuroCure Cluster of Excellence, Charité, 10117 Berlin, Germany cbirch@mdc-berl…

Zitieren

APA

Birchmeier, C. (2025). The two faces of MyoD: repressor and activator of gene expression during myogenesis. Genes & Development. https://doi.org/10.1101/gad.353232.125

Vancouver

Birchmeier C. The two faces of MyoD: repressor and activator of gene expression during myogenesis. Genes & Development. 2025. doi:10.1101/gad.353232.125

BibTeX
@article{Birchmeier2025,
  author = {Birchmeier, Carmen},
  title = {The two faces of MyoD: repressor and activator of gene expression during myogenesis},
  journal = {Genes & Development},
  year = {2025},
  doi = {10.1101/gad.353232.125}
}
Kostenlos starten →